European journal of medicinal chemistry
Patel BD, Ghate MD.
PMID: 24531198
Eur J Med Chem. 2014 Mar 03;74:574-605. doi: 10.1016/j.ejmech.2013.12.038. Epub 2014 Jan 11.
Dipeptidyl peptidase-4 (DPP-4) is one of the widely explored novel targets for Type 2 diabetes mellitus (T2DM) currently. Research has been focused on the strategy to preserve the endogenous glucagon like peptide (GLP)-1 activity by inhibiting the DPP-4 action....
Cite
Patel BD, Ghate MD. Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors. Eur J Med Chem. 2014;74:574-605doi: 10.1016/j.ejmech.2013.12.038.
Patel, B. D., & Ghate, M. D. (2014). Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors. European journal of medicinal chemistry, 74574-605. https://doi.org/10.1016/j.ejmech.2013.12.038
Patel, Bhumika D, and Ghate, Manjunath D. "Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors." European journal of medicinal chemistry vol. 74 (2014): 574-605. doi: https://doi.org/10.1016/j.ejmech.2013.12.038
Patel BD, Ghate MD. Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors. Eur J Med Chem. 2014 Mar 03;74:574-605. doi: 10.1016/j.ejmech.2013.12.038. Epub 2014 Jan 11. PMID: 24531198.
Copy
Download .nbib
